11-Methoxyyangonin

CAS No. 2743-14-8

11-Methoxyyangonin( Trimethylhispidin | NSC212503 )

Catalog No. M29444 CAS No. 2743-14-8

11-Methoxyyangonin is a natural kavalactone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 264 Get Quote
25MG 447 Get Quote
50MG 626 Get Quote
100MG 885 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    11-Methoxyyangonin
  • Note
    Research use only, not for human use.
  • Brief Description
    11-Methoxyyangonin is a natural kavalactone.
  • Description
    11-Methoxyyangonin is a natural kavalactone.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Trimethylhispidin | NSC212503
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2743-14-8
  • Formula Weight
    288.3
  • Molecular Formula
    C16H16O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 16.67 mg/mL (57.82 mM)
  • SMILES
    COC(C=C(C=Cc(cc1)cc(OC)c1OC)O1)=CC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Emedastine

    Emedastine is a second generation, selective histamine H1 receptor antagonist with anti-allergic activity.

  • ELA-32 (human)

    Potent, high affinity apelin receptor agonist (IC50 = 0.27 nM; Kd = 0.51 nM). Exhibits no binding GPR15 and GPR25. Activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. Also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. Stimulates angiogenesis in HUVEC cells. Relaxes mouse aortic vessels. Functions as an anorexigenic hormone through activation of the AVP and CRH neurons in the PVN.

  • OGT inhibitor 4a

    OGT inhibitor 4a is an O-linked n-acetylglucosaminyltransferase (OGT) inhibitor with anticancer activity for the study of autoimmune and neurological disorders.